Cargando…
Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms
BACKGROUND: Multiple system atrophy (MSA) is a rare progressive neurodegenerative disorder for which brief yet sensitive scale is required in order for use in clinical trials and general screening. We previously compared several scales for the assessment of MSA symptoms and devised an eight-item pil...
Autores principales: | Matsushima, Masaaki, Yabe, Ichiro, Takahashi, Ikuko, Hirotani, Makoto, Kano, Takahiro, Horiuchi, Kazuhiro, Houzen, Hideki, Sasaki, Hidenao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496135/ https://www.ncbi.nlm.nih.gov/pubmed/28680652 http://dx.doi.org/10.1186/s40673-017-0067-5 |
Ejemplares similares
-
Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis
por: Takahashi, Ikuko, et al.
Publicado: (2015) -
Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
por: Houzen, Hideki, et al.
Publicado: (2021) -
Genomic copy number variation analysis in multiple system atrophy
por: Hama, Yuka, et al.
Publicado: (2017) -
Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson’s disease
por: Uwatoko, Hisashi, et al.
Publicado: (2019) -
Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
por: Kitta, Takeya, et al.
Publicado: (2018)